Peripheral Arterial Disease Drugs Market - Global Outlook and Forecast 2021-2027

Code: RW00014556262
Market Monitor Global
Oct-2021
Life Sciences
94 Pages

This report contains market size and forecasts of Peripheral Arterial Disease (PAD) Drugs in Global, including the following market information:
Global Peripheral Arterial Disease (PAD) Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Peripheral Arterial Disease (PAD) Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peripheral Arterial Disease (PAD) Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peripheral Arterial Disease (PAD) Drugs Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Peripheral Arterial Disease (PAD) Drugs Market Segment Percentages, By Type, 2020 (%)
Clopidogrel (Plavix)
Prasugrel (Effient)
Ticagrelor (Brilinta)
Vorapaxar (Zontivity)
Others

China Peripheral Arterial Disease (PAD) Drugs Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Peripheral Arterial Disease (PAD) Drugs Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics
Others

Global Peripheral Arterial Disease (PAD) Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Peripheral Arterial Disease (PAD) Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Peripheral Arterial Disease (PAD) Drugs Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Peripheral Arterial Disease (PAD) Drugs Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
AstraZeneca (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co (US)
Proteon Therapeutics (US)
Sanofi (France)
Symic Bio (US)
TheraVasc (US)

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Peripheral Arterial Disease (PAD) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peripheral Arterial Disease (PAD) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peripheral Arterial Disease (PAD) Drugs Overall Market Size
2.1 Global Peripheral Arterial Disease (PAD) Drugs Market Size: 2021 VS 2027
2.2 Global Peripheral Arterial Disease (PAD) Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peripheral Arterial Disease (PAD) Drugs Players in Global Market
3.2 Top Global Peripheral Arterial Disease (PAD) Drugs Companies Ranked by Revenue
3.3 Global Peripheral Arterial Disease (PAD) Drugs Revenue by Companies
3.4 Top 3 and Top 5 Peripheral Arterial Disease (PAD) Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies Peripheral Arterial Disease (PAD) Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peripheral Arterial Disease (PAD) Drugs Players in Global Market
3.6.1 List of Global Tier 1 Peripheral Arterial Disease (PAD) Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Peripheral Arterial Disease (PAD) Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Peripheral Arterial Disease (PAD) Drugs Market Size Markets, 2021 & 2027
4.1.2 Clopidogrel (Plavix)
4.1.3 Prasugrel (Effient)
4.1.4 Ticagrelor (Brilinta)
4.1.5 Vorapaxar (Zontivity)
4.1.6 Others
4.2 By Type - Global Peripheral Arterial Disease (PAD) Drugs Revenue & Forecasts
4.2.1 By Type - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2016-2021
4.2.2 By Type - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2022-2027
4.2.3 By Type - Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peripheral Arterial Disease (PAD) Drugs Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Peripheral Arterial Disease (PAD) Drugs Revenue & Forecasts
5.2.1 By Application - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2016-2021
5.2.2 By Application - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2022-2027
5.2.3 By Application - Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Peripheral Arterial Disease (PAD) Drugs Market Size, 2021 & 2027
6.2 By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue & Forecasts
6.2.1 By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2016-2021
6.2.2 By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2022-2027
6.2.3 By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Peripheral Arterial Disease (PAD) Drugs Revenue, 2016-2027
6.3.2 US Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.3.3 Canada Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.3.4 Mexico Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Peripheral Arterial Disease (PAD) Drugs Revenue, 2016-2027
6.4.2 Germany Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.4.3 France Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.4.4 U.K. Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.4.5 Italy Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.4.6 Russia Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.4.7 Nordic Countries Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.4.8 Benelux Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Peripheral Arterial Disease (PAD) Drugs Revenue, 2016-2027
6.5.2 China Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.5.3 Japan Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.5.4 South Korea Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.5.5 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.5.6 India Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Peripheral Arterial Disease (PAD) Drugs Revenue, 2016-2027
6.6.2 Brazil Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.6.3 Argentina Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue, 2016-2027
6.7.2 Turkey Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.7.3 Israel Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.7.4 Saudi Arabia Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
6.7.5 UAE Peripheral Arterial Disease (PAD) Drugs Market Size, 2016-2027
7 Players Profiles
7.1 AstraZeneca (UK)
7.1.1 AstraZeneca (UK) Corporate Summary
7.1.2 AstraZeneca (UK) Business Overview
7.1.3 AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.1.4 AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Revenue in Global (2016-2021)
7.1.5 AstraZeneca (UK) Key News
7.2 Bayer HealthCare Pharmaceuticals (Germany)
7.2.1 Bayer HealthCare Pharmaceuticals (Germany) Corporate Summary
7.2.2 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
7.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.2.4 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Revenue in Global (2016-2021)
7.2.5 Bayer HealthCare Pharmaceuticals (Germany) Key News
7.3 Bristol-Myers Squibb Company (US)
7.3.1 Bristol-Myers Squibb Company (US) Corporate Summary
7.3.2 Bristol-Myers Squibb Company (US) Business Overview
7.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.3.4 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Revenue in Global (2016-2021)
7.3.5 Bristol-Myers Squibb Company (US) Key News
7.4 Merck & Co (US)
7.4.1 Merck & Co (US) Corporate Summary
7.4.2 Merck & Co (US) Business Overview
7.4.3 Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.4.4 Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Revenue in Global (2016-2021)
7.4.5 Merck & Co (US) Key News
7.5 Proteon Therapeutics (US)
7.5.1 Proteon Therapeutics (US) Corporate Summary
7.5.2 Proteon Therapeutics (US) Business Overview
7.5.3 Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.5.4 Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Revenue in Global (2016-2021)
7.5.5 Proteon Therapeutics (US) Key News
7.6 Sanofi (France)
7.6.1 Sanofi (France) Corporate Summary
7.6.2 Sanofi (France) Business Overview
7.6.3 Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.6.4 Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Revenue in Global (2016-2021)
7.6.5 Sanofi (France) Key News
7.7 Symic Bio (US)
7.7.1 Symic Bio (US) Corporate Summary
7.7.2 Symic Bio (US) Business Overview
7.7.3 Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.4.4 Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Revenue in Global (2016-2021)
7.7.5 Symic Bio (US) Key News
7.8 TheraVasc (US)
7.8.1 TheraVasc (US) Corporate Summary
7.8.2 TheraVasc (US) Business Overview
7.8.3 TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.8.4 TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Revenue in Global (2016-2021)
7.8.5 TheraVasc (US) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Peripheral Arterial Disease (PAD) Drugs Market Opportunities & Trends in Global Market
Table 2. Peripheral Arterial Disease (PAD) Drugs Market Drivers in Global Market
Table 3. Peripheral Arterial Disease (PAD) Drugs Market Restraints in Global Market
Table 4. Key Players of Peripheral Arterial Disease (PAD) Drugs in Global Market
Table 5. Top Peripheral Arterial Disease (PAD) Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Peripheral Arterial Disease (PAD) Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Peripheral Arterial Disease (PAD) Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies Peripheral Arterial Disease (PAD) Drugs Product Type
Table 9. List of Global Tier 1 Peripheral Arterial Disease (PAD) Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peripheral Arterial Disease (PAD) Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE